II. Definitions
- Primary Amenorrhea
- Secondary Amenorrhea
-
Oligomenorrhea
- Cycle greater than 35 day cycles (>45 days in adolescents)
III. Causes
- See Hypogonadism
- Axis 1: Hypothalamus or Central
- Anovulation (10% of primary causes)
- Constitutional (6% of primary causes): Family History
- Gonadotropin deficiency such as Kallmann's Syndrome (Rare): Associated with Anosmia
- Axis 2: Pituitary
- Hyperprolactinemia (2% of primary causes)
- Pituitary Tumor (8% of primary causes)
- Pituitary Adenoma (Hormone producing)
- Pituitary Null Cell Tumor (No Hormone produced)
- Empty Sella Syndrome
- Pituitary Tuberculosis
- Pituitary Schistosomiasis
- Axis 3: Ovarian
- Polycystic Ovary Syndrome (10% of primary causes)
- Findings: Obesity, Hirsutism, and Acne Vulgaris
- Turner Syndrome and Mosaics (30% of primary causes)
- Findings: Short Stature, Web neck, and Shield Chest
- May present as Amenorrhea and Short Stature alone
- Genetic Male (10% of primary causes)
- Gonadal dysgenesis
- Polycystic Ovary Syndrome (10% of primary causes)
- Axis 4: Uterus
- Mullerian Agenesis (20% of primary causes)
- Mayer-Rokitansky-Kuster-Hauser Syndrome
- Imperforate Hymen
- Transverse vaginal septum
- Complete androgen resistance
- Mullerian Agenesis (20% of primary causes)
IV. History
- See Amenorrhea
V. Exam
- See Amenorrhea
VI. Labs
- See Amenorrhea
- First Line
- Advanced Testing for Hyperandrogenism Findings
- Other testing
- 17-Hydroxyprogesterone (8 am, Congenital Adrenal Hyperplasia)
- Antimullerian Hormone (premature ovarian insufficiency)
- Karyotype Indications
- Hypergonadotropic Hypogonadism
- Short Stature
- Abnormal female anatomy
- Noniatrogenic premature ovarian insufficiency
VII. Imaging
- See Amenorrhea
- Pelvic Ultrasound (first-line)
- Evaluate for Uterine presence (or signs of outflow obstruction)
- Advanced Imaging
- Abdomen and Pelvis MRI Indications
- Abnormal reproductive anatomy
- Androgen Secreting tumors (Adrenal Adenoma)
- Brain MRI Indications
- Pituitary and other CNS Lesions
- Abdomen and Pelvis MRI Indications
VIII. Evaluation: Protocol based on LH, FSH and Pelvic Ultrasound
- Obtain first-line testing as above
- Manage positive Pregnancy Test (including Ectopic Pregnancy consideration)
- Manage Hypothyroidism
- Evaluate Hyperprolactinemia
-
Uterus Present
- Low Serum FSH and Serum LH (Hypogonadotropic Hypogonadism)
- GnRH Deficiency (rare)
- Functional Hypothalamic Amenorrhea (e.g. Relative Energy Deficiency in Sport)
- Constitutional delay of Puberty
- Normal Serum FSH and Serum LH (Normogonadotropic Hypogonadism)
- Consider Obstruction to flow
- Imperforate Hymen
- Transverse vaginal septum
- Consider Hyperandrogenism (e.g. Hirsutism)
- Polycystic Ovary Syndrome
- Adrenal tumor
- Ovarian tumor
- Consider other causes
- See Secondary Amenorrhea
- Delayed Puberty
- New pituitary Tumor
- Consider Obstruction to flow
- High Serum FSH and Serum LH (Hypergonadotropic Hypogonadism)
- Reflects Primary Ovarian Insufficiency
- Karyotype
- Karyotype 46 XX (normal)
- Suggests pituitary Defect
- Turner Syndrome
- Monosomy X (45,X)
- Mosaicism (e.g. 45,X / 46,XX)
- Y Chromatin (Y Chromosome)
- Swyer syndrome (46,XY gonadal dysgenesis)
- Mosaic Turner Syndrome
- Karyotype 46 XX (normal)
- Other Primary Ovarian Insufficiency labs
- FMR1 Gene Premutation (fragile-X gene)
- 21-Hydroxylase autoantibodies (Autoimmune Adrenalitis and Addison's Disease)
- Premature Ovarian Insufficiency secondary to Autoimmune Polyendocrine Syndrome
- Low Serum FSH and Serum LH (Hypogonadotropic Hypogonadism)
-
Uterus Absent
- Obtain Karyotype, Free Testosterone and Total Testosterone
- Female range Serum Testosterone and 46 XX
- Mullerian Agenesis
- Male range Serum Testosterone and 46 XY (genetic male)
- Androgen Insensitivity Syndrome (Male Pseudo-Hermaphrodite)
- 5a-Reductase Deficiency
IX. Evaluation: Protocol based on Growth and Development (Female Tanner Stage, Delayed Linear Growth, Uterus Presence)
- Obtain first-line testing as above
- Manage positive Pregnancy Test
- Manage Hypothyroidism
- Manage Hyperprolactinemia
- Abnormal Breast development and Female Tanner Stage
- Normal Height with low gonadotopins (FSH, LH <5 IU)
- See Hypogonadotropic Hypogonadism
- Obtain Karyotype (previously Buccal Smear)
- Karyotype normal
- GnRH Deficient (rare)
- Functional Hypothalamic Amenorrhea
- Constitutional delay of Puberty
- Karyotype abnormal
- Pure Gonadal dysgenesis
- Karyotype normal
- Short Height and excess gonadotropins (FSH>20, LH>40)
- See Hypergonadotropic Hypogonadism
- Reflects Primary Ovarian Insufficiency
- Obtain Karyotype (previously Buccal Smear)
- Karyotype 46 XX
- Pituitary Defect
- Karyotype 45 XO
- Karyotype 46 XX
- Normal Height with low gonadotopins (FSH, LH <5 IU)
- Normal Breast development and Female Tanner Stage
- See Normogonadotropic Hypogonadism
- Uterus Absent on Ultrasound
- Karyotype (previously Buccal Smear)
- Karyotype 46 XX
- Mullerian agenesis (Mullerian Dysgenesis)
- Serum Testosterone in normal female range
- Karyotype 46 XY (genetic male)
- Androgen insensitivity syndrome (Male Pseudo-Hermaphrodite)
- 5a-Reductase Deficiency
- Serum Testosterone in normal Male range
- Uterus Present on Ultrasound
- Consider obstruction to flow
- Imperforate Hymen
- Transverse vaginal septum
- Consider Hyperandrogenism (e.g. Hirsutism)
- Polycystic Ovary Syndrome
- Adrenal tumor
- Ovarian tumor
- Consider other causes
- See Secondary Amenorrhea
- Delayed Puberty
- New pituitary Tumor
- Consider obstruction to flow
X. References
- (2008) Fertil Steril 90(5 suppl): S219-25 [PubMed]
- Klein (2019) Am Fam Physician 100(1): 39-48 [PubMed]
- Klein (2013) Am Fam Physician 87(11): 781-88 [PubMed]
- Master-Hunter (2006) Am Fam Physician 73:1374-87 [PubMed]
- Pletcher (1999) Pediatr Clin North Am 46:505-18 [PubMed]
- Timmreck (2003) Obstet Gynecol Clin North Am 30:287-302 [PubMed]